LORAZEPAM AND HYDROMORPHONE FOR CONSCIOUS SEDATION AND ANALGESIA
LORAZEPAM AND HYDROMORPHONE FOR CONSCIOUS SEDATION AND ANALGESIA
批准号:
6117354
负责人:
T E WITZIG
金额:
$2.26万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
接受骨髓活检的患者将接受以下预处理:
氯西泮和氢吗啡酮,以评估该方案是否会减少
与单纯局部麻醉相比,
该方案是一项双盲安慰剂对照试验,
接受双侧骨髓活检的患者的镇痛
淋巴瘤分期 我们的假设是病人会经历
当他们服用口服止痛药时,疼痛和痛苦会减少。
英文摘要
Patients undergoing bone marrow biopsy will be premedicated with
lorzepam and hydromorphone to assess whether this regimen will reduce
anxiety and pain compared to local anesthesia alone.
This protocol was a double-blind placebo controlled trial of oral
analgesia for patients undergoing bilateral bone marrow biopsies for
staging of lymphoma. Our hypothesis was that patients would experience
less pain and distress when they had oral analgesics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHASE II TRIAL OF IV SODIUM PHENYLACETATE IN B CELL CLL
-
批准号:6117360
-
项目类别:
-
资助金额:$2.01万
-
财政年份:1998
-
负责人:T E WITZIG
-
依托单位:
PHASE II TRIAL OF IV SODIUM PHENYLACETATE IN B CELL CLL
-
批准号:6248609
-
项目类别:
-
资助金额:$2.45万
-
财政年份:1997
-
负责人:T E WITZIG
-
依托单位:
LORAZEPAM AND HYDROMORPHONE FOR CONSCIOUS SEDATION AND ANALGESIA
-
批准号:6248599
-
项目类别:
-
资助金额:$2.45万
-
财政年份:1997
-
负责人:T E WITZIG
-
依托单位:
LORAZEPAM AND HYDROMORPHONE FOR CONSCIOUS SEDATION AND ANALGESIA
-
批准号:6278549
-
项目类别:
-
资助金额:$2.03万
-
财政年份:1997
-
负责人:T E WITZIG
-
依托单位:
PHASE II TRIAL OF IV SODIUM PHENYLACETATE IN B CELL CLL
-
批准号:6278555
-
项目类别:
-
资助金额:$2.03万
-
财政年份:1997
-
负责人:T E WITZIG
-
依托单位:
LORAZEPAM AND HYDROMORPHONE FOR CONSCIOUS SEDATION AND ANALGESIA
-
批准号:5220767
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:T E WITZIG
-
依托单位:--
PHASE II TRIAL OF IV SODIUM PHENYLACETATE IN B CELL CLL
-
批准号:3742727
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:T E WITZIG
-
依托单位:
PHASE II TRIAL OF IV SODIUM PHENYLACETATE IN B CELL CLL
-
批准号:5220784
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:T E WITZIG
-
依托单位:--
LORAZEPAM AND HYDROMORPHONE FOR CONSCIOUS SEDATION AND ANALGESIA
-
批准号:3742695
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:T E WITZIG
-
依托单位:
海外基金